These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 14433433)
41. Response to trifluoperazine and chlorpromazine, singly and in combination, in chronic, "backward" patients. TERRELL MS Dis Nerv Syst; 1962 Jan; 23():41-8. PubMed ID: 13920357 [No Abstract] [Full Text] [Related]
42. Studies on a new anticholinergic substance with marked antisecretory effect. STEIGMANN F; PAMUKCU F; CHUNG KS Am J Gastroenterol; 1960 Jan; 33():109-16. PubMed ID: 13834074 [No Abstract] [Full Text] [Related]
44. The treatment of psychoneurotic conditions with trifluoperazine. BRAM G Br J Clin Pract; 1960 Feb; 14():107-9. PubMed ID: 13803809 [No Abstract] [Full Text] [Related]
45. Maintenance therapy in gastrointestinal disorders; 18-month study of a new anticholinergic. HOFFMANN CR Am J Gastroenterol; 1959 Sep; 32():370-4. PubMed ID: 14402423 [No Abstract] [Full Text] [Related]
46. Evaluation of ambutonium bromide in the management of gastrointestinal disease. ROSSMAN M Am J Gastroenterol; 1960 Oct; 34():414-8. PubMed ID: 13743751 [No Abstract] [Full Text] [Related]
47. Trifluoperazine in the treatment of drug-resistant schizophrenics. ALLEN VS J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1959; 20():247-50. PubMed ID: 13792788 [No Abstract] [Full Text] [Related]
48. Treatment of chronic digestive dysfunctions with an entozyme compound tablet. KETY SS Am J Gastroenterol; 1960 Jan; 33():106-8. PubMed ID: 14408715 [No Abstract] [Full Text] [Related]
49. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics. KRUSE W Am J Psychiatry; 1960 Dec; 117():548-9. PubMed ID: 13754637 [No Abstract] [Full Text] [Related]
50. [Contribution to the cases on trifluoperazine in psychiatric therapeutics]. ACUSSE RUIZ G; NONINI J; BLASQUEZ S Sem Med; 1962 Jun; 120():1512-5. PubMed ID: 13859225 [No Abstract] [Full Text] [Related]
51. [Notes on Aludrox in digestive therapy]. FEVRIER P Lyon Med; 1962 Mar; 94():575-9. PubMed ID: 13892676 [No Abstract] [Full Text] [Related]
53. A clinical evaluation of an anticholinergic agent in a sustained-release dose form. HOCK CW Curr Ther Res Clin Exp; 1962 Jul; 4():363-9. PubMed ID: 13907921 [No Abstract] [Full Text] [Related]
54. [Clinical evaluation of trifluoperazine in pediatrics]. VEZINA N Union Med Can; 1960 Apr; 89():436-44. PubMed ID: 13842027 [No Abstract] [Full Text] [Related]
56. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation. LESSE S N Y State J Med; 1961 Jun; 61():1898-903. PubMed ID: 13761180 [No Abstract] [Full Text] [Related]
57. Trifluoperazine and amylobarbitone in the treatment of psychoneurosis. LAZARUS S Appl Ther; 1962 Aug; 4():725-8. PubMed ID: 14463101 [No Abstract] [Full Text] [Related]
59. [Experience with trifluoperazine in psychiatric clinical practice]. ROSA JJ; MONTENEGRO AE; MINDLIN E Sem Med; 1961 Dec; 119():2056-66. PubMed ID: 14493772 [No Abstract] [Full Text] [Related]
60. Combined tranlcypromine and trifluoperazine therapy in general medicine. LEWIS RA Can Psychiatr Assoc J; 1962; 7(Suppl)():74-6. PubMed ID: 14464901 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]